Bariatric surgery (sleeve gastrectomy) after liver transplantation: case report

Pajecki, Dênis; Cesconetto, Danielle Menezes; Macacari, Rodrigo; Joaquim, Henrique; Andraus, Wellington; Cleva, Roberto de; Santo, Marco Aurélio; D’Albuquerque, Luiz Augusto Carneiro; Cecconello, Ivan

doi:10.1590/s0102-6720201400s100021

Cited by 14 publications

(7 citation statements)

References 10 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is no prospective study in the literature comparing the combined LT + SG to SG after LT. Many case reports and two case series have described that laparoscopic and robotic‐assisted sleeve gastrectomy post‐LT are feasible. Combined surgery (LT + SG) represents a single operation and recovery process for the patient, thus avoiding a more hostile operative field attributed to adhesions and altered anatomy, as well as other potential barriers to weight loss surgery such as insurance coverage, or delays attributed to complications such as rejection, infection, or disease recurrence.…”

Section: Discussionmentioning

confidence: 99%

Long‐term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy

Zamora-Valdés¹,

Watt²,

Kellogg³

et al. 2018

Hepatology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Long‐term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy

Zamora-Valdés¹,

Watt²,

Kellogg³

et al. 2018

Hepatology

View full text Add to dashboard Cite

show abstract

“…Such aggression can be observed in even young patients, sometimes requiring even early liver transplantation 25 .…”

Section: Introductionmentioning

confidence: 99%

Correlation of Non-Alcoholic Fatty Liver Disease and Features of Metabolic Syndrome in Morbidly Obese Patients in the Preoperative Assessment for Bariatric Surgery

Barros¹,

Setúbal

Martinho

et al. 2016

ABCD, arq. bras. cir. dig.

View full text Add to dashboard Cite

Background: Obesity is an epidemic and chronic disease that can bring other comorbidities to the patient. Non-alcoholic fatty liver disease is present in up to 90% of these patients and can progress to hepatitis and hepatocarcinoma. The relationship of this liver disease and obesity is already well known; however, it is possible that some parameters of the comorbidities are more related than others in the pathophysiology of the disease. Aim: Was analyzed the relationship between non-alcoholic fatty liver disease (NAFLD) and the comorbidities of metabolic syndrome in morbidly obese patients. Methods: Was involved ultrasonography and laboratory assessment of obese patients before bariatric surgery. NAFLD was assessed using the same sonography parameters for all patients. Based on the results, the patients were divided into groups with and without NAFLD. Comparisons between them involved clinical and laboratory variables such as fasting blood glucose, insulin, HOMA-IR (homeostasis model assessment - insulin resistance), glycated hemoglobin, total cholesterol and fractions, triglycerides, alanine aminotransferase, aspartate aminotransferase, gamma glutamyl transferase, C-reactive protein, albumin and ferritin. Patients who reported alcohol abuse (defined as the consumption of >14 drinks per week) or who had hepatitis were excluded. Results: Eighty-two patients (74 women and 8 men) were studied, of whom 53 (64.6%) had NAFLD and 29 (35.4%) did not. The levels of glycated hemoglobin (p=0.05) and LDL cholesterol (p=0.01) were significantly altered in patients with NAFLD. However, weight, body mass index and excess weight did not differ significantly between the groups (p=0.835, p=0.488 and p=0.727, respectively). Conclusions: Altered LDL cholesterol and glycated hemoglobin levels were related to the presence of NAFLD.

show abstract

“…Morbidity is higher than in the general population (reoperation rate of up to 33%) but mortality is similar. 21,22,[28][29][30] conclusion…”

Section: Resultsmentioning

confidence: 99%

Bariatric surgery in individuals with liver cirrhosis: A narrative review

Cazzo

Gestic

Chaim

et al. 2017

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

Summary Introduction: Bariatric surgery has become the gold standard treatment for morbid obesity, but there is no consensus regarding its safety and efficacy among individuals with chronic liver diseases. Objective: To critically evaluate the existing evidence on literature about bariatric surgery in individuals with liver cirrhosis. Method: Narrative review performed by means of an online search in the MEDLINE and LILACS databases. Results: Bariatric surgery is safe and effective in individuals with chronic liver disease without clinical decompensation or significant portal hypertension. Individuals with severe liver function impairment present significantly higher surgical morbidity and mortality. Among candidates to liver transplantation, surgery may be performed before, after and even during transplantation, and there is a predominant trend to perform it after. Vertical sleeve gastrectomy seems to be the most adequate technique in this group of subjects. Conclusion: Bariatric surgery is safe and effective in individuals with compensated cirrhosis without significant portal hypertension, but presents higher morbidity. Among candidates to liver transplantation and/or individuals with severe portal hypertension, morbidity and mortality are significantly higher.

show abstract

Bariatric surgery (sleeve gastrectomy) after liver transplantation: case report

Cited by 14 publications

References 10 publications

Long‐term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy

Long‐term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy

Correlation of Non-Alcoholic Fatty Liver Disease and Features of Metabolic Syndrome in Morbidly Obese Patients in the Preoperative Assessment for Bariatric Surgery

Bariatric surgery in individuals with liver cirrhosis: A narrative review

Contact Info

Product

Resources

About